PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsArm1
Arm1
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5323 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HepatitisD006505K75.92991121
Hepatitis aD006506EFO_0007305B152551113
Type 2 diabetes mellitusD003924EFO_0001360E1132318
Rheumatoid arthritisD001172EFO_0000685M06.9112116
ArthritisD001168EFO_0005856M05-M14112116
Diabetes mellitusD003920EFO_0000400E08-E1322216
Hepatitis bD00650912215
InfectionsD007239EFO_0000544112
Chronic hepatitis bD019694EFO_0004239B18.11112
Atrial fibrillationD001281EFO_0000275I48.011
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis cD006526B19.2479121
CarcinomaD002277C80.04217
HepacivirusD016174437
Lung neoplasmsD008175C34.903517
Multiple myelomaD009101C90.0516
Chronic hepatitis cD019698EFO_0004220B18.21326
MelanomaD0085452215
Prostatic neoplasmsD011471C611515
Non-small-cell lung carcinomaD0022892315
Plasma cell neoplasmsD054219314
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients415
LeukemiaD007938C95134
DepressionD003863F33.9134
Myeloid leukemiaD007951C92213
Breast neoplasmsD001943EFO_0003869C50123
Depressive disorderD003866EFO_1002014F32.A33
Small cell lung carcinomaD055752223
Colorectal neoplasmsD015179122
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340112
LymphomaD008223C85.9112
Show 34 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8066
HypercholesterolemiaD00693722
AtherosclerosisD050197EFO_0003914I25.122
Gastrointestinal neoplasmsD005770C26.911
Intestinal neoplasmsD007414C26.011
Nose neoplasmsD009669C76.011
B-cell lymphomaD01639311
Hematologic neoplasmsD01933711
Non-hodgkin lymphomaD008228C85.911
Hodgkin diseaseD006689C8111
Show 9 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use